Today: 9 June 2026
Trump’s Iran deadline and Aldar’s $1bn Apollo notes: Week ahead on Abu Dhabi’s ADX
22 February 2026
2 mins read

Trump’s Iran deadline and Aldar’s $1bn Apollo notes: Week ahead on Abu Dhabi’s ADX

Abu Dhabi, February 22, 2026, 11:48 (GST) — Trading has ended; the market is closed.

  • Abu Dhabi’s main index slipped 0.3% Friday as U.S.-Iran tensions resurfaced.
  • Aldar slid 2.6% after word got out about its $1 billion subordinated hybrid note deal with Apollo.
  • Invictus shares climbed 1.6% after the company posted a 34% jump in full-year profit.

Abu Dhabi’s main index slipped 0.3% Friday as traders digested fresh U.S.-Iran tensions—President Donald Trump set Tehran a 10–15 day deadline for nuclear talks. Aldar Properties dropped 2.6%, Agility Global was down 1.4%. Invictus Investment gained 1.6% on the back of its profit update. Dubai’s benchmark closed 0.3% lower as well. Brent crude eased 0.4% to finish at $71.38 a barrel.

ADX tends to double as a barometer for geopolitical sentiment when headlines start moving. Oil’s still the primary force, unsurprisingly, and even robust company updates often fade quickly into the background.

The index hovered close to 10,581 points at Friday’s close, according to Trading Economics data. Now, Abu Dhabi traders are eyeing Monday’s open—watching for hints that the recent wave of selling is either exhausted or just taking a breather.

Aldar is back in the spotlight, securing a $1.0 billion private placement of subordinated hybrid notes from Apollo Global Management. These notes, which mix debt and equity features, are slated to go in as equity for Aldar Investment Properties. The deal also lets Aldar retire $500 million in perpetual hybrid notes—those went to Apollo in 2022—raising Aldar’s stake in that unit to 90%. CFO Faisal Falaknaz called the capital “long-term, flexible,” aimed at “enhancing balance sheet resilience.” On Apollo’s side, partner Jamshid Ehsani said this marks their fifth transaction with Aldar, a nod to Apollo’s ability to deliver “flexible capital solutions.” vazeno.files.cmp.optimizely.com

The stock slid hard on Friday, a reminder of how fast rate or risk news can take over, whatever the structure. Some traders are eyeing potential buying interest, especially if oil prices stabilize.

Invictus delivered clean figures: audited 2025 EBITDA hit 458.5 million dirhams, soaring 184%. Revenue reached 13.3 billion, up 49%. Net profit came in at 227.6 million, up 37%. The board’s offering—a 40 million dirham cash payout. CEO Amir Daoud Abdellatif called 2025 “a defining year,” pointing to a revamped investment approach, with Invictus chasing 25 billion dirhams in revenue by 2028. apigateway.adx.ae

Now, the focus shifts to whether specific company stories can break through as the broader market enters a key phase. If risk sentiment takes a hit, stocks linked to property, banks, and energy tend to get battered first.

Here’s the risk: it’s clear-cut, tilted in just one direction. Escalating U.S.-Iran news could trigger another rapid wave of de-risking. ADX liquidity can run thin, especially when big names start sliding all at once—there’s not always much of a buffer.

ADX will halt trading in Emirates Telecom Group (Etisalat Group) shares from 13:00 local time on Feb. 24, according to the local schedule. The suspension stays in effect until the board meeting ends and results are released, putting one of the exchange’s heavyweights on ice for now.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
Previous Story

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

Robinhood stock: what to know before Monday after Goldman trims target, filing tweaks annual report
Next Story

Robinhood stock: what to know before Monday after Goldman trims target, filing tweaks annual report

Go toTop